The Management Committee is composed of the Chair, Administrative Director and two other committee members. This committee is responsible for the daily management of CAIRE.
The 2000-2015 Management Committee
Dr Ward received his medical training at McGill University (1980) followed by residencies/fellowships in Internal Medicine (1988) and Infectious Diseases (1990) at Johns Hopkins and in Microbiology at McGill (1991). His research training began at Oxford as a Rhodes Scholar (MSc 1980) and continued at Johns Hopkins (1986-90). He joined the Faculty of Medicine at McGill in 1991. He is currently professor of Medicine and Microbiology as well as Associate Director of the Research Institute of the McGill University Health Centre (Fundamental Science). He is also Associate Director of the JD MacLean Centre for Tropical Diseases, Co-Director of the McGill Vaccine Study Centre and Medical Director of the National Reference Laboratory for Parasitology.
Working at BC Children’s Hospital Dr. Scheifele is a Professor of Pediatrics in Infectious Diseases. He is Director of the Vaccine Evaluation Center (VEC), established in 1988. The VEC was Canada’s first academic vaccine research center and remains one of the largest and most active. He is the Founding Chair of CAIRE, 2000-present. Clinical Trials Co-lead, Public Health Agency/Canadian Institutes of Health Research Influenza Research Network (PCIRN) (2009-present), a key component of Canada’s pandemic preparedness infrastructure. Co-founder, Canadian Immunization Monitoring Program, Active (IMPACT) and Data Center chief (1991- present). IMPACT links 12 centers across Canada (including BCH) in active surveillance of vaccine-preventable infections and vaccine safety monitoring.
Dr. Scott Halperin is a Professor of Pediatrics and Microbiology and Immunology at Dalhousie University and Head of Pediatric Infectious Diseases at the IWK Health Centre in Halifax. As Director of the Canadian Center for Vaccinology and Nominated Principal Investigator of both the Public Health Agency/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and its newly established successor, the Canadian Immunization Research Network (CIRN), Dr. Halperin is at the forefront of efforts to provide Canada with a national capacity to undertake coordinated, integrated, evaluative vaccine research to inform public health policy and practice. He leads an interdisciplinary team of more than 110 investigators in more than 45 institutions involved in collaborative research projects of priority to Canadian health. Dr. Halperin’s key area of expertise is pertussis (whooping cough). His research focuses on the diagnosis, treatment, and prevention of pertussis and other vaccine-preventable diseases.
Gordean Bjornson, MBA
Vaccine Evaluation Center
University of British Columbia, Department of Pediatrics
Gordean is a Research Administrator at the Vaccine Evaluation Center (VEC). Since 2000, Gordean has also been the Administrator for the Canadian Association for Immunization Research and Evaluation (CAIRE) whose office is located at the VEC. In her role with CAIRE she has helped to conceptualize and organize numerous research-oriented workshops, consultations with vaccine manufacturers and educational initiatives.
Dr. David Scheifele
Gordean Bjornson, MBA